BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1438446)

  • 1. Detection of minimal residual breast cancer in bone marrow.
    Johnston CS; Shpall EJ; Williams S; Hami L; Jones RB; Bast RC; Ceriani RL; Franklin W
    Prog Clin Biol Res; 1992; 377():637-42. PubMed ID: 1438446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunocytologic tumor cell detection in bone marrow of breast cancer patients].
    Schwarz I; Eichfeld U; Gläser A
    Z Arztl Fortbild (Jena); 1992 Oct; 86(19):977-80. PubMed ID: 1441634
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolated tumor cells in bone marrow of early-stage breast cancer patients.
    Singletary SE
    J Am Coll Surg; 2006 Aug; 203(2):240-9; quiz A58-9. PubMed ID: 16864036
    [No Abstract]   [Full Text] [Related]  

  • 4. A monoclonal antibody cocktail for detection of micrometastatic tumor cells in the bone marrow of breast cancer patients.
    Taha M; Ordoñez NG; Kulkarni S; Owen M; Ro JS; Hortobagyi G; Reading CL; Dicke KA; Spitzer G
    Bone Marrow Transplant; 1989 May; 4(3):297-303. PubMed ID: 2471564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histological tumor type and bone marrow metastases of cancers of the breast].
    Soudah B; Stauch G; Spindler B; Nicolai U; Georgii A
    Verh Dtsch Ges Pathol; 1985; 69():338-41. PubMed ID: 4096114
    [No Abstract]   [Full Text] [Related]  

  • 6. Micrometastasis in bone marrow in breast cancer.
    Basu D; Singh T; Shinghal RN
    Indian J Pathol Microbiol; 1994 Apr; 37(2):159-64. PubMed ID: 7959982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of microscopic bone marrow cells may predict breast cancer recurrence.
    Oncology (Williston Park); 1991 Nov; 5(11):106. PubMed ID: 1837225
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer.
    Giai M; Natoli C; Sismondi P; Biglia N; Lesti G; Mulieri M; Iacobelli S
    Anticancer Res; 1990; 10(1):119-21. PubMed ID: 2334117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of tumor cells in bone marrow: a deciding aid for adjuvant therapy in node negative patients with breast cancer. Concept for a multicenter study and results of the pilot phase].
    Funke I; Fries S; Jauch KW
    Chirurg; 1991 Nov; 62(11):805-9. PubMed ID: 1769261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Micrometastases in bone marrow at the time of primary treatment of breast cancer: a new prognostic criterion?].
    Untch M; Harbeck N; Eiermann W
    Gynakol Rundsch; 1989; 29 Suppl 2():231-3. PubMed ID: 2693244
    [No Abstract]   [Full Text] [Related]  

  • 11. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
    Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
    Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow.
    Osborne MP; Wong GY; Asina S; Old LJ; Cote RJ; Rosen PP
    Cancer Res; 1991 May; 51(10):2706-9. PubMed ID: 2021949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Technical aspects of immunocytochemical detection of disseminated tumor cells in bone marrow].
    Braun S
    Acta Med Austriaca Suppl; 2002; 59():14-7. PubMed ID: 12506755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
    Diel IJ; Cote RJ
    Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Minimal residual disease in breast carcinoma].
    Janků F; Novotný J; Vedralová J; Kleibl Z; Matous B; Petruzelka L
    Cas Lek Cesk; 2002 Aug; 141(17):546-50. PubMed ID: 12404958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of detection of tumor cells in human bone marrow with or without prior culture.
    Joshi SS; Novak DJ; Messbarger L; Maitreyan V; Weisenburger DD; Sharp JG
    Bone Marrow Transplant; 1990 Sep; 6(3):179-83. PubMed ID: 2252957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapy.
    Vredenburgh JJ; Peters WP; Rosner G; DeSombre K; Johnston WW; Kamel A; Wu K; Bast RC
    Bone Marrow Transplant; 1995 Dec; 16(6):815-21. PubMed ID: 8750275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis in the bone marrow of patients with breast cancer.
    Chavez-Macgregor M; Aviles-Salas A; Green D; Fuentes-Alburo A; Gómez-Ruiz C; Aguayo A
    Clin Cancer Res; 2005 Aug; 11(15):5396-400. PubMed ID: 16061853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor biology of primary breast cancer and minimal residual disease].
    Schindlbeck C; Janni W; Schaffer P; Shabani N; Schmitt M; Harbeck N; Sommer H; Braun S
    Acta Med Austriaca Suppl; 2002; 59():27-31. PubMed ID: 12506757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system.
    Kraeft SK; Sutherland R; Gravelin L; Hu GH; Ferland LH; Richardson P; Elias A; Chen LB
    Clin Cancer Res; 2000 Feb; 6(2):434-42. PubMed ID: 10690521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.